*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : WM3380000
CHEMICAL NAME : Succinaldehydic acid
CAS REGISTRY NUMBER : 692-29-5
BEILSTEIN REFERENCE NO. : 1745187
REFERENCE : 4-03-00-01554 (Beilstein Handbook Reference)
LAST UPDATED : 199712
DATA ITEMS CITED : 4
MOLECULAR FORMULA : C4-H6-O3
MOLECULAR WEIGHT : 102.10
WISWESSER LINE NOTATION : VH2VQ
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* Butanoic acid, 4-oxo-
* Butryaldehydic acid
* 3-Formylpropanoic acid
* beta-Formylpropionic acid
* 3-Formylpropionic acid
* 4-Oxobutanoic acid
* gamma-Oxybutyric acid
* Semi-aldehyde succinique
* Succinic acid semialdehyde
* Succinic semialdehyde
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FMXXAJ French Medicament Patent Document. (U.S. Patent and Trademark
Office, Foreign Patents, Washington, DC 20231) Discontinued.
Volume(issue)/page/year: #3296M
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1900 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - muscle weakness
REFERENCE :
PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation
of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1-
1967- Volume(issue)/page/year: 3,697,1969
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FMXXAJ French Medicament Patent Document. (U.S. Patent and Trademark
Office, Foreign Patents, Washington, DC 20231) Discontinued.
Volume(issue)/page/year: #3296M
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : >3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FMXXAJ French Medicament Patent Document. (U.S. Patent and Trademark
Office, Foreign Patents, Washington, DC 20231) Discontinued.
Volume(issue)/page/year: #3296M
*** END OF RECORD ***